The Global Urinary Stones Treatment Devices Market size is estimated to hit around USD 8.52 billion by 2033, increasing from USD 4.12 billion in 2026, growing with a CAGR of 8.98% from 2026 to 2033.
The Global Urinary Stones Treatment Devices Market comprises medical devices used for the diagnosis, fragmentation, removal, and management of kidney and urinary tract stones. These devices include extracorporeal shock wave lithotripsy (ESWL) systems, ureteroscopes, laser lithotripsy devices, nephroscopes, stone retrieval baskets, and accessory tools used in minimally invasive and surgical procedures. The market serves hospitals, ambulatory surgery centers, and specialty urology clinics. Growth is driven by the rising prevalence of urolithiasis, lifestyle-related risk factors, and technological advancements that enable minimally invasive procedures with faster recovery times, improved clinical outcomes, and reduced hospital stays.
Key trends in the global urinary stones treatment devices market include the growing adoption of minimally invasive and non-invasive technologies, such as laser lithotripsy and advanced ureteroscopy systems. Holmium and thulium fiber lasers are gaining popularity due to higher precision and improved stone fragmentation efficiency. The shift toward outpatient procedures and ambulatory surgical centers is also influencing device design and adoption. Additionally, manufacturers are focusing on single-use disposable devices to reduce infection risks and improve procedural efficiency. Integration of imaging technologies and digital visualization systems further enhances procedural accuracy. Emerging economies are witnessing increased adoption due to improving healthcare infrastructure and rising awareness of advanced urological treatments.
Segmentation: The Global Urinary Stones Treatment Devices Market is segmented by Treatment Type (Ureteroscopy, Percutaneous Nephrolithotomy (PCNL), Extracorporeal Shock Wave Lithotripsy (ESWL), Open Surgery, and Others), Stone Type (Calcium Oxalate Stones, Uric Acid Stones, Struvite Stones, Cystine Stones and Others), Product Type (Stone Retrieval Devices, Ureteral Access Devices, Lithotripters, Ultrasonic Lithotripters, Pneumatic Lithotripters, Catheters & Stents, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the value (in USD million) for the above segments.
Market Drivers:
A major driver of the global urinary stones treatment devices market is the rising prevalence of urolithiasis worldwide. For instance, in 2025, the Asian Institute of Nephrology and Urology reported a severe spike in kidney stone cases, treating over 300 patients daily and noting rising incidence among school children. This surge increased demand for urinary stones treatment devices globally, accelerating adoption of advanced lithotripsy and minimally invasive technologies, and driving innovation in heat-related stone management solutions.
Factors such as poor dietary habits, dehydration, obesity, metabolic disorders, and aging populations have significantly increased the incidence of kidney and urinary tract stones. Recurrent stone formation often requires repeated interventions, boosting demand for advanced treatment devices. Growing awareness among patients and physicians regarding early diagnosis and minimally invasive treatment options further accelerates adoption. As stone disease affects both developed and developing regions, healthcare providers increasingly rely on efficient, high-performance devices to manage increasing patient volumes, directly supporting sustained market growth.
Technological advancements in urology devices represent another key driver of market growth. Innovations such as high-power laser lithotripsy systems, flexible digital ureteroscopes, and enhanced imaging technologies have improved stone clearance rates and reduced procedural complications.
In January 2026, SonoMotion received FDA 510(k) clearance for its Break Wave lithotripsy device, a non-invasive, anesthesia-free treatment that uses low-pressure focused ultrasound and real-time imaging to fragment kidney stones. This approval strengthened the Global Urinary Stones Treatment Devices Market by expanding non-invasive treatment options, boosting the adoption of ultrasound-based lithotripsy, and advancing technological innovation in patient-friendly stone management. These advancements enable shorter procedure times, lower retreatment rates, and improved patient comfort. The shift toward minimally invasive and outpatient-based procedures aligns with healthcare providers’ goals of improving efficiency and reducing costs.
Additionally, continuous product upgrades and the introduction of single-use devices address infection control concerns, making advanced urinary stone treatment devices increasingly attractive to hospitals and ambulatory surgery centers worldwide.
Market Restraints:
A key restraint in the global urinary stones treatment devices market is the high cost associated with advanced equipment and procedures. Devices such as laser lithotripsy systems and digital ureteroscopes require significant capital investment, limiting adoption in smaller hospitals and resource-constrained settings. Maintenance costs, need for skilled professionals, and training requirements further add to the financial burden. In developing regions, limited healthcare infrastructure and reimbursement challenges restrict access to advanced treatment technologies. Additionally, the availability of alternative conservative management options for small stones may delay device-based interventions, restraining market growth in certain patient populations.
The urinary stones treatment devices market plays a significant role in reducing the healthcare burden associated with recurrent kidney stone disease. Effective and minimally invasive treatments help lower hospitalization duration, reduce complication rates, and minimize productivity losses caused by prolonged recovery. Early intervention and improved device accessibility support better patient outcomes and reduce long-term healthcare costs. The market also contributes to job creation across medical device manufacturing, healthcare delivery, and R&D sectors. In developing regions, improved access to advanced stone treatment technologies enhances quality of life and reduces disparities in urological care. Overall, advancements in treatment devices support sustainable healthcare systems and improved patient well-being globally.
Segmental Analysis
The Extracorporeal Shock Wave Lithotripsy (ESWL) segment is expected to witness the highest growth over the forecast period due to its non-invasive nature and strong clinical acceptance for treating small to medium-sized urinary stones. ESWL does not require surgical incisions, anesthesia is minimal, and patients typically experience shorter recovery times, making it a preferred first-line treatment. Continuous advancements in shock wave technology, imaging guidance, and energy control have improved treatment precision and success rates. Increasing patient preference for outpatient and scarless procedures, coupled with rising awareness of early stone management, further supports adoption. Additionally, the availability of compact and cost-effective ESWL systems expands accessibility across hospitals and diagnostic centers, driving segment growth.
The calcium oxalate stones segment is expected to witness the highest growth over the forecast period, driven by the high global prevalence of this stone type. Calcium oxalate stones account for the majority of kidney stone cases and are closely linked to dietary habits, dehydration, metabolic disorders, and lifestyle changes. Rising consumption of processed foods and increasing obesity rates have contributed to higher incidence worldwide. The recurrent nature of calcium oxalate stone formation necessitates repeated diagnostic and interventional procedures, boosting demand for treatment devices. Growing awareness of early diagnosis and preventive care, along with improved treatment modalities, continues to fuel market expansion for this segment across both developed and emerging regions.
The stone retrieval devices segment is expected to witness the highest growth over the forecast period due to increasing adoption of minimally invasive endoscopic procedures such as ureteroscopy and percutaneous nephrolithotomy. Devices including baskets, graspers, and forceps are essential for effective stone extraction following fragmentation procedures. Advancements in flexible materials, enhanced maneuverability, and single-use disposable designs have improved procedural efficiency and reduced infection risks. Rising preference for endoscopic stone removal techniques, supported by improved visualization and laser technologies, further accelerates demand. Additionally, the growing number of outpatient urological procedures and expansion of ambulatory surgical centers globally contribute to the strong growth outlook for stone retrieval devices.
North America is expected to witness the highest growth in the urinary stones treatment devices market over the forecast period, supported by advanced healthcare infrastructure and high disease prevalence.
The region records a significant incidence of kidney stone disease due to dietary patterns, sedentary lifestyles, and metabolic conditions. Strong adoption of advanced treatment technologies, including ESWL, laser lithotripsy, and minimally invasive endoscopic devices, drives market growth.
Favorable reimbursement policies, high healthcare spending, and the presence of leading medical device manufacturers further strengthen the market. For instance, in January 2026, The FDA granted 510(k) clearance for SonoMotion’s ultrasound-based Break Wave lithotripsy device, offering a new treatment option for kidney stone patients. This approval strengthened North America’s Urinary Stones Treatment Devices Market by expanding access to non-invasive, ultrasound-guided stone fragmentation technology. It also supported innovation in minimally invasive care and increased clinical adoption of advanced lithotripsy solutions in the region. Additionally, increasing patient awareness and access to specialized urology care contribute to sustained regional demand for advanced urinary stones treatment devices.
The global urinary stones treatment devices market is moderately competitive, with the presence of established multinational medical device companies and specialized urology-focused manufacturers. Leading players compete through technological innovation, product portfolio expansion, and strategic collaborations with hospitals and urology clinics. Companies are investing heavily in R&D to develop advanced laser systems, digital endoscopes, and minimally invasive solutions. Mergers, acquisitions, and geographic expansion strategies are commonly used to strengthen market presence. While large players dominate developed markets, regional manufacturers are gaining traction in emerging economies by offering cost-effective solutions. Competitive differentiation is driven by device efficacy, safety, ease of use, and after-sales support.
The major players for the above market are:
Recent Development
Q1. What are the main growth-driving factors for this market?
The primary growth drivers are the increasing prevalence of urolithiasis due to changing dietary habits, rising obesity rates, and sedentary lifestyles. Technological advancements, such as minimally invasive ureteroscopy and high-power holmium lasers, improve success rates. Additionally, the aging global population and rising healthcare expenditures facilitate wider adoption of advanced treatments.
Q2. What are the main restraining factors for this market?
Growth is restrained by the high cost of advanced surgical systems and lithotripsy equipment, which limits adoption in developing regions. Potential complications associated with invasive procedures and the availability of alternative pharmaceutical treatments also hinder market expansion. Furthermore, stringent regulatory approval processes for new medical devices can delay product launches.
Q3. Which segment is expected to witness high growth?
The ureteroscopy segment is expected to witness the highest growth due to its minimally invasive nature and high efficacy in treating diverse stone types. The increasing preference for outpatient procedures and the development of flexible, single-use ureteroscopes significantly contribute to this segment’s expansion over traditional shock-wave lithotripsy or open surgeries.
Q4. Who are the top major players for this market?
Key market players include Boston Scientific Corporation, Olympus Corporation, C.R. Bard (Becton, Dickinson and Company), and Cook Medical. Other prominent companies are Richard Wolf GmbH, Dornier MedTech, and Lumenis (Boston Scientific). These leaders maintain their positions through continuous innovation in fiber optics, laser technology, and specialized stone extraction tools.
Q5. Which country is the largest player?
The United States is the largest player in the urinary stones treatment market. Its dominance is supported by a sophisticated healthcare system, high rates of kidney stone diagnosis, and early adoption of robotic-assisted technologies. Furthermore, favorable reimbursement policies and significant investments in research and development sustain its leading global position.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
